• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过对MET受体酪氨酸激酶结构域进行深度突变扫描揭示了近膜结构域和激酶N叶中的保守调控基序。

Conserved regulatory motifs in the juxtamembrane domain and kinase N-lobe revealed through deep mutational scanning of the MET receptor tyrosine kinase domain.

作者信息

Estevam Gabriella O, Linossi Edmond M, Macdonald Christian B, Espinoza Carla A, Michaud Jennifer M, Coyote-Maestas Willow, Collisson Eric A, Jura Natalia, Fraser James S

机构信息

Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco,United States.

Tetrad Graduate Program, University of California San Francisco, San Francisco, United States.

出版信息

bioRxiv. 2024 May 6:2023.08.03.551866. doi: 10.1101/2023.08.03.551866.

DOI:10.1101/2023.08.03.551866
PMID:37577651
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10418267/
Abstract

MET is a receptor tyrosine kinase (RTK) responsible for initiating signaling pathways involved in development and wound repair. MET activation relies on ligand binding to the extracellular receptor, which prompts dimerization, intracellular phosphorylation, and recruitment of associated signaling proteins. Mutations, which are predominantly observed clinically in the intracellular juxtamembrane and kinase domains, can disrupt typical MET regulatory mechanisms. Understanding how juxtamembrane variants, such as exon 14 skipping (METΔEx14), and rare kinase domain mutations can increase signaling, often leading to cancer, remains a challenge. Here, we perform a parallel deep mutational scan (DMS) of the MET intracellular kinase domain in two fusion protein backgrounds: wild type and METΔEx14. Our comparative approach has revealed a critical hydrophobic interaction between a juxtamembrane segment and the kinase αC-helix, pointing to potential differences in regulatory mechanisms between MET and other RTKs. Additionally, we have uncovered a β5 motif that acts as a structural pivot for the kinase domain in MET and other TAM family of kinases. We also describe a number of previously unknown activating mutations, aiding the effort to annotate driver, passenger, and drug resistance mutations in the MET kinase domain.

摘要

MET是一种受体酪氨酸激酶(RTK),负责启动参与发育和伤口修复的信号通路。MET的激活依赖于配体与细胞外受体的结合,这会促使二聚化、细胞内磷酸化以及相关信号蛋白的募集。临床上主要在细胞内近膜区和激酶结构域观察到的突变,可能会破坏典型的MET调节机制。了解近膜区变体(如14号外显子跳跃,即METΔEx14)和罕见的激酶结构域突变如何增加信号传导并常常导致癌症,仍然是一项挑战。在此,我们在两种融合蛋白背景下对MET细胞内激酶结构域进行了平行深度突变扫描(DMS):野生型和METΔEx14。我们的比较方法揭示了近膜区片段与激酶αC螺旋之间关键的疏水相互作用,这表明MET与其他RTK在调节机制上可能存在差异。此外,我们发现了一个β5基序,它是MET和其他TAM激酶家族中激酶结构域的结构枢纽。我们还描述了一些以前未知的激活突变,有助于对MET激酶结构域中的驱动突变、乘客突变和耐药突变进行注释。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b49/11105868/55a8ff73b32d/nihpp-2023.08.03.551866v3-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b49/11105868/82398d0ad945/nihpp-2023.08.03.551866v3-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b49/11105868/309285b6ff2d/nihpp-2023.08.03.551866v3-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b49/11105868/d8ff8585ac1d/nihpp-2023.08.03.551866v3-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b49/11105868/a0cc5c0cf6c7/nihpp-2023.08.03.551866v3-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b49/11105868/0262781ef976/nihpp-2023.08.03.551866v3-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b49/11105868/55a8ff73b32d/nihpp-2023.08.03.551866v3-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b49/11105868/82398d0ad945/nihpp-2023.08.03.551866v3-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b49/11105868/309285b6ff2d/nihpp-2023.08.03.551866v3-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b49/11105868/d8ff8585ac1d/nihpp-2023.08.03.551866v3-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b49/11105868/a0cc5c0cf6c7/nihpp-2023.08.03.551866v3-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b49/11105868/0262781ef976/nihpp-2023.08.03.551866v3-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b49/11105868/55a8ff73b32d/nihpp-2023.08.03.551866v3-f0006.jpg

相似文献

1
Conserved regulatory motifs in the juxtamembrane domain and kinase N-lobe revealed through deep mutational scanning of the MET receptor tyrosine kinase domain.通过对MET受体酪氨酸激酶结构域进行深度突变扫描揭示了近膜结构域和激酶N叶中的保守调控基序。
bioRxiv. 2024 May 6:2023.08.03.551866. doi: 10.1101/2023.08.03.551866.
2
Conserved regulatory motifs in the juxtamembrane domain and kinase N-lobe revealed through deep mutational scanning of the MET receptor tyrosine kinase domain.通过对 MET 受体酪氨酸激酶结构域的深度突变扫描揭示了近膜结构域和激酶 N-结构域中的保守调控基序。
Elife. 2024 Sep 13;12:RP91619. doi: 10.7554/eLife.91619.
3
A conserved DpYR motif in the juxtamembrane domain of the Met receptor family forms an atypical c-Cbl/Cbl-b tyrosine kinase binding domain binding site required for suppression of oncogenic activation.Met受体家族近膜结构域中一个保守的DpYR基序形成了一个非典型的c-Cbl/Cbl-b酪氨酸激酶结合结构域结合位点,该位点是抑制致癌激活所必需的。
J Biol Chem. 2004 Jul 9;279(28):29565-71. doi: 10.1074/jbc.M403954200. Epub 2004 Apr 29.
4
Mapping kinase domain resistance mechanisms for the MET receptor tyrosine kinase via deep mutational scanning.通过深度突变扫描绘制MET受体酪氨酸激酶的激酶结构域耐药机制图谱。
bioRxiv. 2024 Dec 5:2024.07.16.603579. doi: 10.1101/2024.07.16.603579.
5
Loss of the exon encoding the juxtamembrane domain is essential for the oncogenic activation of TPR-MET.编码近膜结构域的外显子缺失对于TPR-MET的致癌激活至关重要。
Oncogene. 1999 Jul 22;18(29):4275-81. doi: 10.1038/sj.onc.1202791.
6
Alternatively spliced juxtamembrane domain of a tyrosine kinase receptor is a multifunctional regulatory site. Deletion alters cellular tyrosine phosphorylation pattern and facilitates binding of phosphatidylinositol-3-OH kinase to the hepatocyte growth factor receptor.酪氨酸激酶受体的可变剪接近膜结构域是一个多功能调节位点。缺失会改变细胞酪氨酸磷酸化模式,并促进磷脂酰肌醇-3-羟基激酶与肝细胞生长因子受体的结合。
J Biol Chem. 1995 Jan 13;270(2):507-10. doi: 10.1074/jbc.270.2.507.
7
c-MET mutational analysis in small cell lung cancer: novel juxtamembrane domain mutations regulating cytoskeletal functions.小细胞肺癌中的c-MET突变分析:调节细胞骨架功能的新型近膜结构域突变
Cancer Res. 2003 Oct 1;63(19):6272-81.
8
A juxtamembrane autophosphorylation site in the Eph family receptor tyrosine kinase, Sek, mediates high affinity interaction with p59fyn.Eph家族受体酪氨酸激酶Sek中的一个近膜自磷酸化位点介导了与p59fyn的高亲和力相互作用。
Oncogene. 1996 Apr 18;12(8):1727-36.
9
MET in human cancer: germline and somatic mutations.人类癌症中的MET:种系突变和体细胞突变。
Ann Transl Med. 2017 May;5(10):205. doi: 10.21037/atm.2017.03.64.
10
The ErbB/HER family of protein-tyrosine kinases and cancer.表皮生长因子受体(ErbB)/HER 家族蛋白酪氨酸激酶与癌症。
Pharmacol Res. 2014 Jan;79:34-74. doi: 10.1016/j.phrs.2013.11.002. Epub 2013 Nov 20.

本文引用的文献

1
Profiling of drug resistance in Src kinase at scale uncovers a regulatory network coupling autoinhibition and catalytic domain dynamics.大规模分析Src 激酶的耐药性揭示了一个调节网络,该网络将自身抑制和催化结构域动力学偶联起来。
Cell Chem Biol. 2024 Feb 15;31(2):207-220.e11. doi: 10.1016/j.chembiol.2023.08.005. Epub 2023 Sep 7.
2
Dimerization and autophosphorylation of the MST family of kinases are controlled by the same set of residues.MST 家族激酶的二聚化和自身磷酸化受同一组残基控制。
Biochem J. 2023 Aug 16;480(15):1165-1182. doi: 10.1042/BCJ20230067.
3
DIMPLE: deep insertion, deletion, and missense mutation libraries for exploring protein variation in evolution, disease, and biology.
DIMPLE:用于探索蛋白质在进化、疾病和生物学中的变异的深度插入、缺失和错义突变文库。
Genome Biol. 2023 Feb 24;24(1):36. doi: 10.1186/s13059-023-02880-6.
4
Identification of MET fusions as novel therapeutic targets sensitive to MET inhibitors in lung cancer.鉴定肺癌中 MET 融合作为对 MET 抑制剂敏感的新型治疗靶点。
J Transl Med. 2023 Feb 25;21(1):150. doi: 10.1186/s12967-023-03999-7.
5
Response and acquired resistance to MET inhibitors in de novo MET fusion-positive advanced non-small cell lung cancer.初治MET融合阳性晚期非小细胞肺癌对MET抑制剂的反应及获得性耐药
Lung Cancer. 2023 Apr;178:66-74. doi: 10.1016/j.lungcan.2023.01.017. Epub 2023 Feb 1.
6
MET exon 14 skipping mutation is a hepatocyte growth factor (HGF)-dependent oncogenic driver in vitro and in humanised HGF knock-in mice.MET 外显子 14 跳跃突变是体外和人源化 HGF 敲入小鼠中肝细胞生长因子 (HGF) 依赖性致癌驱动因素。
Mol Oncol. 2023 Nov;17(11):2257-2274. doi: 10.1002/1878-0261.13397. Epub 2023 Jul 14.
7
UniProt: the Universal Protein Knowledgebase in 2023.UniProt:2023 年的通用蛋白质知识库。
Nucleic Acids Res. 2023 Jan 6;51(D1):D523-D531. doi: 10.1093/nar/gkac1052.
8
Saturation mutagenesis of a predicted ancestral Syk-family kinase.预测的祖先 Syk 家族激酶的饱和诱变。
Protein Sci. 2022 Oct;31(10):e4411. doi: 10.1002/pro.4411.
9
Durable response to crizotinib in an advanced lung adenocarcinoma patient harboring rare fusion: a case report.一例罕见融合基因的晚期肺腺癌患者对克唑替尼的持久反应:病例报告
Transl Cancer Res. 2022 Aug;11(8):2931-2935. doi: 10.21037/tcr-22-141.
10
Activation of the essential kinase PDK1 by phosphoinositide-driven trans-autophosphorylation.通过磷酸肌醇驱动的转自磷酸化激活必需激酶 PDK1。
Nat Commun. 2022 Apr 6;13(1):1874. doi: 10.1038/s41467-022-29368-4.